Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development by Iftikhar, Ahmad, Hassan, Hamza, Iftikhar, Nimra, Mushtaq, Adeela, Sohail, Atif, Rosko, Nathaniel, Chakraborty, Rajshekhar, Razzaq, Faryal, Sandeep, Sonia, Valent, Jason Neil, Kanate, Abraham Sebastian, Anwer, Faiz

Get full text

Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma by Basali, Diana, Chakraborty, Rajshekhar, Rybicki, Lisa, Rosko, Nathaniel, Reed, Janice, Karam, Maryann, Schlueter, Kristen, Dysert, Hayley, Kalaycio, Matt, Valent, Jason

Get full text

Treatment of relapsed multiple myeloma: Evidence-based recommendations by Durer, Ceren, Durer, Seren, Lee, Sarah, Chakraborty, Rajshekhar, Malik, Mustafa Nadeem, Rafae, Abdul, Zar, Muhammad Abu, Kamal, Ahmad, Rosko, Nathaniel, Samaras, Christy, Valent, Jason, Chaulagain, Chakra, Anwer, Faiz

Get full text

Abnormal Metaphase Cytogenetics Adds to Currently Known Risk-Factors for Venous Thromboembolism in Multiple Myeloma: Derivation of the PRISM score by Chakraborty, Rajshekhar, Rybicki, Lisa, Valent, Jason, Mejia Garcia, Alex V., Faiman, Beth M., Khouri, Jack, Rosko, Nathaniel, Samaras, Christy J., Kalaycio, Matt, Anwer, Faiz, Khorana, Alok A

Get full text

Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma by Chakraborty, Rajshekhar, Rybicki, Lisa, Nakashima, Megan O., Dean, Robert M., Faiman, Beth M., Samaras, Christy J., Rosko, Nathaniel, Dysert, Hayley, Valent, Jason, Anwer, Faiz

Get full text

Cost and Value Analysis of Standard Versus Rapid Daratumumab Infusion in Multiple Myeloma by Lee, Sarah S, Rosko, Nathaniel, Pinnamaneni, Pramod, Savage, Craig, Mejia Garcia, Alex V., Samaras, Christy J., Valent, Jason

Get full text

Real-World Data on Safety and Efficacy of Venetoclax-Based Regimens in Relapsed/Refractory t[11;14] Multiple Myeloma by Basali, Diana, Chakraborty, Rajshekhar, Rybicki, Lisa, Rosko, Nathaniel, Reed, Janice, Karam, Mary Ann, Schlueter, Kristen, Dysert, Hayley, Faiman, Beth M., Hamilton, Kimberly, Kalaycio, Matt, Valent, Jason

Get full text

Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma by Chakraborty, Rajshekar, Rybicki, Lisa, Nakashima, Megan, Dean, Robert M., Faiman, Beth M., Samaras, Christy J., Rosko, Nathaniel, Valent, Jason, Anwer, Faiz

Get full text

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients by Covut, Fahrettin, Ahmed, Ramsha, Samaras, Christy J., Anwer, Faiz, Mejia Garcia, Alex V., Angelini, Dana E, Faiman, Beth M., Reed, Janice, Karam, Mary Ann, Schlueter, Kristen, Mathur, Saveta, Hamilton, Kimberly, Rosko, Nathaniel, Valent, Jason, Khouri, Jack

Get full text

Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis by Rosko, Nathaniel, Mo, Hanjie, Rudoni, Joslyn, Siebenaller, Caitlin, Lee, Sarah S, Chakraborty, Rajshekar, Faiman, Beth M., Khouri, Jack, Mejia Garcia, Alex V., Samaras, Christy J., Anwer, Faiz, Valent, Jason

Get full text

Rapid Hematologic and Organ Responses with Daratumumab, Bortezomib and Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis by Lee, Sarah S, Rosko, Nathaniel, Patel, Bhumika J., Waldron, Madeline, Tomer, Jackie, Goldman, Roman, Karam, Mary Ann, Reed, Janice, Faiman, Beth M., Hamilton, Kimberly, Mathur, Saveta, Samaras, Christy J., Valent, Jason

Get full text

A Phase 1/2 Trial of Low-Dose Continuous Azacitidine in Combination with Lenalidomide and Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma by Khouri, Jack, Faiman, Beth, Wei, Wei, Grabowski, Dale, Samaras, Christy Joy, mahfouz, Reda, Lazarus, Hillard, Dean, Robert, Malek, Eshan, Reed, Janice, Karam, Mary Ann, Hamilton, Kimberly, Rosko, Nathaniel, Fada, Sherry, Kalaycio, Matt, Liu, Hien, Saunthararajah, Yogen, Chew, Yap, Valent, Jason, Reu, Frederic

Get full text